Theratechnologies Inc (TSE:TH) – National Bank Financial dropped their FY2020 earnings estimates for shares of Theratechnologies in a report released on Tuesday, October 8th. National Bank Financial analyst E. Leno now expects that the company will post earnings per share of $0.27 for the year, down from their prior estimate of $0.30. National Bank Financial has a “Sector Perform” rating and a $7.00 price target on the stock.
Theratechnologies (TSE:TH) last released its earnings results on Thursday, July 11th. The company reported C($0.06) earnings per share (EPS) for the quarter. The company had revenue of C$20.92 million during the quarter, compared to analysts’ expectations of C$26.00 million.
TSE:TH opened at C$4.90 on Thursday. The firm has a market cap of $387.84 million and a PE ratio of -55.06. The stock has a fifty day moving average price of C$5.35 and a 200 day moving average price of C$6.27. Theratechnologies has a 12-month low of C$4.71 and a 12-month high of C$9.74. The company has a current ratio of 2.51, a quick ratio of 1.94 and a debt-to-equity ratio of 167.71.
Theratechnologies Inc, a specialty pharmaceutical company, addresses unmet medical needs to promote healthy living and improve quality of life among HIV patients. It offers EGRIFTA, for the reduction of excess abdominal fat in HIV-infected patients with lipodystrophy in Canada and the United States; and Trogarz, an injection refers to ibalizumab for the treatment of multidrug resistant HIV-1 infected patients in the United States.
Recommended Story: Stock Symbol
Receive News & Ratings for Theratechnologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Theratechnologies and related companies with MarketBeat.com's FREE daily email newsletter.